Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
Iachettini S, Terrenato I, Porru M, Di Vito S, Rizzo A, D'Angelo C, Petti E, Dinami R, Maresca C, Di Benedetto A, Palange A, Mulè A, Santoro A, Palazzo A, Fuso P, Stoppacciaro A, Vici P, Filomeno L, Di Lisa FS, Arcuri T, Krasniqi E, Fabi A, Biroccio A, Zizza P. Iachettini S, et al. Among authors: stoppacciaro a. J Exp Clin Cancer Res. 2024 Mar 9;43(1):75. doi: 10.1186/s13046-024-02998-w. J Exp Clin Cancer Res. 2024. PMID: 38459559 Free PMC article.
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.
Dinami R, Pompili L, Petti E, Porru M, D'Angelo C, Di Vito S, Rizzo A, Campani V, De Rosa G, Bruna A, Serra V, Mano M, Giacca M, Leonetti C, Ciliberto G, Tarsounas M, Stoppacciaro A, Schoeftner S, Biroccio A. Dinami R, et al. Among authors: stoppacciaro a. EMBO Mol Med. 2023 Jan 11;15(1):e16033. doi: 10.15252/emmm.202216033. Epub 2022 Nov 25. EMBO Mol Med. 2023. PMID: 36426578 Free PMC article.
Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitors.
Rizzo A, Maresca C, D'Angelo C, Porru M, Di Vito S, Salvati E, Sacconi A, Berardinelli F, Sgura A, Kuznetsov S, Potdar S, Hassinen A, Stoppacciaro A, Zizza P, Biroccio A. Rizzo A, et al. Among authors: stoppacciaro a. Aging Cell. 2023 Nov;22(11):e13944. doi: 10.1111/acel.13944. Epub 2023 Oct 19. Aging Cell. 2023. PMID: 37858982 Free PMC article.
"Vanishing" glioblastoma: A case report and review of the literature.
Romano A, De Giorgi S, Romano A, Moltoni G, Ascolese AM, Stoppacciaro A, Bozzao A. Romano A, et al. Among authors: stoppacciaro a. Radiol Case Rep. 2024 May 18;19(8):3276-3282. doi: 10.1016/j.radcr.2024.04.040. eCollection 2024 Aug. Radiol Case Rep. 2024. PMID: 38812592 Free PMC article.
Dural Tail Sign and Middle Meningeal Artery Hypertrophy in Glioblastoma: A Rarity?
Romano A, Moltoni G, Dellepiane F, Palizzi S, Romano A, Guarnera A, Stoppacciaro A, Aqui M, Ius T, Miscusi M, Raco A, Bozzao A. Romano A, et al. Among authors: stoppacciaro a. World Neurosurg. 2023 Aug;176:e240-e245. doi: 10.1016/j.wneu.2023.05.038. Epub 2023 May 17. World Neurosurg. 2023. PMID: 37201790 Free article.
172 results